Rejunacia Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
- Revenue Growth 46.68%
- Profit Growth 141.86%
- Ebitda 10.47%
- Net Worth 58.90%
- Total Assets 65.58%
About Rejunacia Healthcare
Rejunacia Healthcare Private Limited (RHPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 August 2017 (Seven years and five months 9 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Piyush Bedi, Vijay Sharma, and Manish Khatri serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85320RJ2017PTC058959
-
Company No.
058959
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Aug 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Rejunacia Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Sharma
|
Director | 31-Aug-2017 | Current |
|
Piyush Bedi
|
Director | 31-Aug-2017 | Current |
|
Manish Khatri
|
Director | 10-Dec-2022 | Current |
Financial Performance of Rejunacia Healthcare.
Rejunacia Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.68% increase. The company also saw a substantial improvement in profitability, with a 141.86% increase in profit. The company's net worth Soared by an impressive increase of 58.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rejunacia Healthcare?
Unlock access to Rejunacia Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 May 2024 | Others | ₹1.50 M | Open |
How Many Employees Work at Rejunacia Healthcare?
Unlock and access historical data on people associated with Rejunacia Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rejunacia Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rejunacia Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.